Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF)

Compare
0.4696
0.0000
(0.00%)
At close: April 4 at 4:00:00 PM EDT
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
5,280,713.4108
5,280,713.4108
5,445,572.0601
7,159,410.6844
6,365,177.4834
Cost of Revenue
3,524,558.2471
3,524,558.2471
3,645,268.7483
4,825,009.7527
4,332,138.3960
Gross Profit
1,756,155.1637
1,756,155.1637
1,800,303.3118
2,334,400.9317
2,033,039.0874
Operating Expense
1,013,647.9200
1,013,647.9200
1,160,308.2436
1,211,852.2741
1,068,874.3955
Operating Income
742,507.2437
742,507.2437
639,995.0683
1,122,548.6577
964,164.6920
Net Non Operating Interest Income Expense
-109,115.2930
-109,115.2930
-199,175.0279
-203,087.7062
-162,846.7215
Pretax Income
726,229.2576
726,229.2576
-928,333.8345
829,850.9586
222,262.9371
Tax Provision
101,311.2221
101,311.2221
-126,174.6049
114,815.7641
-11,120.4881
Net Income Common Stockholders
646,741.6665
646,741.6665
-783,258.0394
727,425.6550
240,787.5787
Basic EPS
-0.10
0.44
-0.53
0.50
0.16
Diluted EPS
-0.10
0.44
-0.53
0.50
0.16
Basic Average Shares
1,467,549.7180
1,467,199.7880
1,467,324.9150
1,468,063.8850
1,467,322.2340
Diluted Average Shares
1,467,549.7180
1,467,199.7880
1,467,324.9150
1,468,063.8850
1,467,322.2340
Total Operating Income as Reported
741,310.9760
741,310.9760
-860,910.8941
828,623.1849
227,474.6978
Total Expenses
4,538,206.1671
4,538,206.1671
4,805,576.9919
6,036,862.0267
5,401,012.7914
Net Income from Continuing & Discontinued Operation
646,741.6665
646,741.6665
-783,258.0394
727,425.6550
240,787.5787
Normalized Income
711,429.1676
711,429.1676
67,246.3872
876,077.1077
466,678.5423
Interest Income
44,374.9482
44,374.9482
39,521.4602
54,138.6388
54,856.8689
Interest Expense
141,184.4263
141,184.4263
223,219.3380
235,242.0673
201,630.9862
Net Interest Income
-109,115.2930
-109,115.2930
-199,175.0279
-203,087.7062
-162,846.7215
EBIT
867,413.6840
867,413.6840
-705,114.4965
1,065,093.0259
423,893.9233
EBITDA
1,198,464.8592
1,198,464.8592
-331,518.4761
1,372,752.4818
726,638.6249
Reconciled Cost of Revenue
3,524,558.2471
3,524,558.2471
3,645,268.7483
4,825,009.7527
4,332,138.3960
Reconciled Depreciation
331,051.1752
331,051.1752
373,596.0204
307,659.4559
302,744.7016
Net Income from Continuing Operation Net Minority Interest
646,741.6665
646,741.6665
-783,258.0394
727,425.6550
240,787.5787
Total Unusual Items Excluding Goodwill
-75,174.5881
-75,174.5881
-984,283.4272
-172,520.9493
-301,187.9516
Total Unusual Items
-75,174.5881
-75,174.5881
-984,283.4272
-172,520.9493
-301,187.9516
Normalized EBITDA
1,273,639.4473
1,273,639.4473
652,764.9511
1,545,273.4311
1,027,826.5765
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0001
0.0003
Tax Effect of Unusual Items
-10,487.0870
-10,487.0870
-133,779.0005
-23,869.4966
-75,296.9879
12/31/2021 - 4/13/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade